AI Portfolio Summary
In 2025 Q4, a16z Capital Management, L.L.C. maintained a portfolio of 13 distinct positions. The most significant new addition to the portfolio was NAVN, which now represents 29.40% of the total fund value. The fund also reduced its exposure to RVMD by 66.5%.
Total Positions
13
Quarter
2025 Q4
Top Holding
FIG (38.4%)
Top 10 Concentration
99.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-13 of 13
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FIG
316841105
|
Technology | 38.43% | 60.41% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
16,246,129 | $607,117,841 |
$51.87
-28.5%
|
2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
NAVN
639193101
|
Technology | 29.40% | — |
#2
Prev: #—
|
9.0 | 27,195,364 | no change |
NEW
|
27,195,364 | $464,496,817 |
$17.08
-4.9%
|
2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
META
30303M102
|
Communication Services | 8.88% | 11.19% |
#3
1
Prev: #2
|
5.6 | no change | no change |
P
S
|
212,531 | $140,289,588 |
$733.15
-11.4%
|
2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
RVMD
76155X100
|
Healthcare | 4.64% | 9.20% |
#4
1
Prev: #3
|
2.4 | -1,827,424 | -66.5% |
P
S
|
921,099 | $73,365,535 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
578784100
|
Healthcare | 4.46% | 3.16% |
#5
1
Prev: #6
|
3.3 | no change | no change |
P
S
|
1,702,225 | $70,523,182 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XYZ
852234103
|
Technology | 4.19% | 5.27% |
#6
1
Prev: #5
|
2.7 | no change | no change |
P
S
|
1,016,697 | $66,176,808 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMDA
68170A108
|
Healthcare | 3.46% | 7.31% |
#7
3
Prev: #4
|
1.4 | -1,153,645 | -25.0% |
P
S
|
3,460,929 | $54,613,460 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIOA
09077V100
|
Healthcare | 2.79% | 1.36% |
#8
1
Prev: #7
|
2.1 | no change | no change |
P
S
|
3,233,170 | $44,068,107 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NAUT
63909J108
|
Healthcare | 2.18% | 1.07% |
#9
1
Prev: #8
|
1.9 | no change | no change |
P
S
|
17,653,917 | $34,425,138 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAMP
13463J101
|
Healthcare | 0.82% | 0.46% |
#10
1
Prev: #9
|
1.3 | no change | no change |
P
S
|
2,125,339 | $13,028,328 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ERAS
29479A108
|
Healthcare | 0.67% | 0.45% |
#11
1
Prev: #10
|
1.3 | no change | no change |
P
S
|
2,862,500 | $10,648,500 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNA
37611X209
|
Healthcare | 0.06% | 0.11% |
#12
1
Prev: #11
|
1.0 | no change | no change |
P
S
|
108,568 | $902,200 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HTBK
426927109
|
Financial Services | 0.01% | — |
#13
Prev: #—
|
3.5 | 82,740 | no change |
NEW
|
82,740 | $129,074 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-13 of 13 holdings